BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 12555992)

  • 61. Distinct patterns of KRAS mutations in colorectal carcinomas according to germline mismatch repair defects and hMLH1 methylation status.
    Oliveira C; Westra JL; Arango D; Ollikainen M; Domingo E; Ferreira A; Velho S; Niessen R; Lagerstedt K; Alhopuro P; Laiho P; Veiga I; Teixeira MR; Ligtenberg M; Kleibeuker JH; Sijmons RH; Plukker JT; Imai K; Lage P; Hamelin R; Albuquerque C; Schwartz S; Lindblom A; Peltomaki P; Yamamoto H; Aaltonen LA; Seruca R; Hofstra RM
    Hum Mol Genet; 2004 Oct; 13(19):2303-11. PubMed ID: 15294875
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Loci for efficient detection of microsatellite instability in hereditary non-polyposis colorectal cancer.
    Frazier ML; Sinicrope FA; Amos CI; Cleary KR; Lynch PM; Levin B; Luthra R
    Oncol Rep; 1999; 6(3):497-505. PubMed ID: 10203581
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Screening for defective DNA mismatch repair in stage II and III colorectal cancer patients.
    Chai SM; Zeps N; Shearwood AM; Grieu F; Charles A; Harvey J; Goldblatt J; Joseph D; Iacopetta B
    Clin Gastroenterol Hepatol; 2004 Nov; 2(11):1017-25. PubMed ID: 15551255
    [TBL] [Abstract][Full Text] [Related]  

  • 64. MLH1 and MSH2 protein expression as a pre-screening marker in hereditary and non-hereditary endometrial hyperplasia and cancer.
    Berends MJ; Hollema H; Wu Y; van Der Sluis T; Mensink RG; ten Hoor KA; Sijmons RH; de Vries EG; Pras E; Mourits MJ; Hofstra RM; Buys CH; Kleibeuker JH; van Der Zee AG
    Int J Cancer; 2001 May; 92(3):398-403. PubMed ID: 11291077
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Clinical analysis and molecular genetic study of hereditary nonpolyposis colorectal cancer kindreds].
    Luo DC; Cai Q; Sun MH; Ni YZ; Tao CW; Chen ZJ; Shi DR
    Zhonghua Wai Ke Za Zhi; 2004 Feb; 42(3):158-62. PubMed ID: 15062061
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Routine testing for mismatch repair deficiency in sporadic colorectal cancer is justified.
    Ward RL; Turner J; Williams R; Pekarsky B; Packham D; Velickovic M; Meagher A; O'Connor T; Hawkins NJ
    J Pathol; 2005 Dec; 207(4):377-84. PubMed ID: 16175654
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The added value of PMS2 immunostaining in the diagnosis of hereditary nonpolyposis colorectal cancer.
    Halvarsson B; Lindblom A; Rambech E; Lagerstedt K; Nilbert M
    Fam Cancer; 2006; 5(4):353-8. PubMed ID: 16817031
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Impact of microsatellite testing and mismatch repair protein expression on the clinical interpretation of genetic testing in hereditary non-polyposis colorectal cancer.
    Ward R; Meldrum C; Williams R; Mokany E; Scott R; Turner J; Hawkins N; Burgess B; Groombridge C; Spigelman A
    J Cancer Res Clin Oncol; 2002 Aug; 128(8):403-11. PubMed ID: 12200596
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Mismatch repair proteins and microsatellites hit clinical practice.
    Stahl J
    Adv Anat Pathol; 2000 Mar; 7(2):85-93. PubMed ID: 10721415
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Multimodal molecular screening is required to improve the sensitivity of MLH1 and MSH2 mutation analysis.
    Andermann A; Thiffault I; Wong N; Gordon P; MacNamara E; Chong G; Foulkes W
    J Clin Oncol; 2002 Mar; 20(6):1705-7. PubMed ID: 11896123
    [No Abstract]   [Full Text] [Related]  

  • 71. Conversion analysis for mutation detection in MLH1 and MSH2 in patients with colorectal cancer.
    Casey G; Lindor NM; Papadopoulos N; Thibodeau SN; Moskow J; Steelman S; Buzin CH; Sommer SS; Collins CE; Butz M; Aronson M; Gallinger S; Barker MA; Young JP; Jass JR; Hopper JL; Diep A; Bapat B; Salem M; Seminara D; Haile R;
    JAMA; 2005 Feb; 293(7):799-809. PubMed ID: 15713769
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Prediction of the outcome of genetic testing in HNPCC kindreds using the revised Amsterdam criteria and immunohistochemistry.
    Stormorken AT; Müller W; Lemkemeyer B; Apold J; Wijnen JT; Fodde R; Möslein G; Møller P
    Fam Cancer; 2001; 1(3-4):169-73. PubMed ID: 14574174
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients.
    Hampel H; Frankel W; Panescu J; Lockman J; Sotamaa K; Fix D; Comeras I; La Jeunesse J; Nakagawa H; Westman JA; Prior TW; Clendenning M; Penzone P; Lombardi J; Dunn P; Cohn DE; Copeland L; Eaton L; Fowler J; Lewandowski G; Vaccarello L; Bell J; Reid G; de la Chapelle A
    Cancer Res; 2006 Aug; 66(15):7810-7. PubMed ID: 16885385
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Mismatch repair deficiency in sporadic synchronous colorectal cancer.
    Brueckl WM; Limmert T; Brabletz T; Guenther K; Jung A; Hermann K; Wiest GH; Kirchner T; Hohenberger W; Hahn EG; Wein A
    Anticancer Res; 2000; 20(6C):4727-32. PubMed ID: 11205208
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Genomic deletions of MSH2 and MLH1 in colorectal cancer families detected by a novel mutation detection approach.
    Gille JJ; Hogervorst FB; Pals G; Wijnen JT; van Schooten RJ; Dommering CJ; Meijer GA; Craanen ME; Nederlof PM; de Jong D; McElgunn CJ; Schouten JP; Menko FH
    Br J Cancer; 2002 Oct; 87(8):892-7. PubMed ID: 12373605
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Causes of microsatellite instability in colorectal tumors: implications for hereditary non-polyposis colorectal cancer screening.
    Potocnik U; Glavac D; Golouh R; Ravnik-Glavac M
    Cancer Genet Cytogenet; 2001 Apr; 126(2):85-96. PubMed ID: 11376800
    [TBL] [Abstract][Full Text] [Related]  

  • 77. MLH1 and MSH2 protein immunohistochemistry is useful for detection of hereditary non-polyposis colorectal cancer in young patients.
    Paraf F; Gilquin M; Longy M; Gilbert B; Gorry P; Petit B; Labrousse F
    Histopathology; 2001 Sep; 39(3):250-8. PubMed ID: 11532035
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Mutations of hMLH1 and hMSH2 in patients with suspected hereditary nonpolyposis colorectal cancer: correlation with microsatellite instability and abnormalities of mismatch repair protein expression.
    Scartozzi M; Bianchi F; Rosati S; Galizia E; Antolini A; Loretelli C; Piga A; Bearzi I; Cellerino R; Porfiri E
    J Clin Oncol; 2002 Mar; 20(5):1203-8. PubMed ID: 11870161
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Spectrum and frequencies of mutations in MSH2 and MLH1 identified in 1,721 German families suspected of hereditary nonpolyposis colorectal cancer.
    Mangold E; Pagenstecher C; Friedl W; Mathiak M; Buettner R; Engel C; Loeffler M; Holinski-Feder E; Müller-Koch Y; Keller G; Schackert HK; Krüger S; Goecke T; Moeslein G; Kloor M; Gebert J; Kunstmann E; Schulmann K; Rüschoff J; Propping P
    Int J Cancer; 2005 Sep; 116(5):692-702. PubMed ID: 15849733
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Microsatellite instability, expression of hMSH2 and hMLH1 and HPV infection in cervical cancer and their clinico-pathological association.
    Chung TK; Cheung TH; Wang VW; Yu MY; Wong YF
    Gynecol Obstet Invest; 2001; 52(2):98-103. PubMed ID: 11586036
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.